학술논문

Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a QID regimen
Document Type
Journal
Source
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY; MAR 2002, 11 2, p114-p123, 10p.
Subject
Language
English
ISSN
10591311